Drugmaker shares rally on US cancer ruling over Zantac


Shares in British pharmaceutical group GlaxoSmithKline and French peer Sanofi jumped Wednesday after a US court dismissed claims that heartburn drug Zantac caused cancer.

Refining how doctors assess hypertension risk

Previous article

Webb Telescope reveals distant planet’s atmosphere

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations